Open AccessMaintenance Olaparib + Bevacizumab Provides Continued Benefit in Ovarian Cancer
Author(s) -
Catlin Nalley
Publication year - 2020
Publication title -
oncology times
Language(s) - English
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000723536.90644.80
Subject(s) - bevacizumab , medicine , olaparib , ovarian cancer , oncology , progression free survival , maintenance therapy , ovarian carcinoma , chemotherapy , gynecology , cancer , biochemistry , chemistry , polymerase , poly adp ribose polymerase , gene